Trademark: 88774747
Status Date
Monday, December 26, 2022
Filing Date
Monday, January 27, 2020
Published for Opposition
Tuesday, September 29, 2020
Abandoned Date
Monday, December 26, 2022
5 Pharmaceuticals for the treatment of cancer, autoimmune diseases, metabolic diseases, or ophthalmic diseases and conditions; Pharmaceutical preparations for the treatment of cancer, autoimmune diseases, metabolic diseases, or ophthalmic diseases and conditions
Dec 27, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Dec 26, 2022
Abandonment - No Use Statement Filed
May 21, 2022
Notice Of Approval Of Extension Request E-Mailed
May 19, 2022
Sou Extension 3 Granted
May 19, 2022
Sou Extension 3 Filed
May 19, 2022
Teas Extension Received
Nov 18, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 16, 2021
Sou Extension 2 Granted
Nov 16, 2021
Sou Extension 2 Filed
Nov 16, 2021
Teas Extension Received
May 8, 2021
Notice Of Approval Of Extension Request E-Mailed
May 6, 2021
Sou Extension 1 Granted
May 6, 2021
Sou Extension 1 Filed
May 6, 2021
Teas Extension Received
Nov 24, 2020
Noa E-Mailed - Sou Required From Applicant
Sep 29, 2020
Official Gazette Publication Confirmation E-Mailed
Sep 29, 2020
Published For Opposition
Sep 9, 2020
Notification Of Notice Of Publication E-Mailed
Aug 27, 2020
Approved For Pub - Principal Register
Aug 26, 2020
Teas/Email Correspondence Entered
Aug 25, 2020
Correspondence Received In Law Office
Aug 25, 2020
Teas Response To Office Action Received
Mar 2, 2020
Notification Of Non-Final Action E-Mailed
Mar 2, 2020
Non-Final Action E-Mailed
Mar 2, 2020
Non-Final Action Written
Feb 27, 2020
Assigned To Examiner
Jan 31, 2020
New Application Office Supplied Data Entered In Tram
Jan 30, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
